These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24612742)

  • 1. A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progression.
    Roca H; Pande M; Huo JS; Hernandez J; Cavalcoli JD; Pienta KJ; McEachin RC
    BMC Syst Biol; 2014 Mar; 8():29. PubMed ID: 24612742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.
    Roca H; Hernandez J; Weidner S; McEachin RC; Fuller D; Sud S; Schumann T; Wilkinson JE; Zaslavsky A; Li H; Maher CA; Daignault-Newton S; Healy PN; Pienta KJ
    PLoS One; 2013; 8(10):e76773. PubMed ID: 24124593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PC-TraFF: identification of potentially collaborating transcription factors using pointwise mutual information.
    Meckbach C; Tacke R; Hua X; Waack S; Wingender E; Gültas M
    BMC Bioinformatics; 2015 Dec; 16():400. PubMed ID: 26627005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OVOL guides the epithelial-hybrid-mesenchymal transition.
    Jia D; Jolly MK; Boareto M; Parsana P; Mooney SM; Pienta KJ; Levine H; Ben-Jacob E
    Oncotarget; 2015 Jun; 6(17):15436-48. PubMed ID: 25944618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
    Recamonde-Mendoza M; Werhli AV; Biolo A
    Gene; 2019 May; 698():157-169. PubMed ID: 30844478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.
    Feng F; Wu J; Gao Z; Yu S; Cui Y
    Medicine (Baltimore); 2017 Jan; 96(1):e5679. PubMed ID: 28072703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models.
    Siletz A; Schnabel M; Kniazeva E; Schumacher AJ; Shin S; Jeruss JS; Shea LD
    PLoS One; 2013; 8(4):e57180. PubMed ID: 23593114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.
    Eisermann K; Tandon S; Bazarov A; Brett A; Fraizer G; Piontkivska H
    BMC Genomics; 2008 Jul; 9():337. PubMed ID: 18631392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved recovery of cell-cycle gene expression in Saccharomyces cerevisiae from regulatory interactions in multiple omics data.
    Panchy NL; Lloyd JP; Shiu SH
    BMC Genomics; 2020 Feb; 21(1):159. PubMed ID: 32054475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
    Jayavelu ND; Bar N
    BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
    Yang L; Feng S; Yang Y
    Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
    Mathews LA; Hurt EM; Zhang X; Farrar WL
    Mol Cancer; 2010 Oct; 9():267. PubMed ID: 20929579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferring coregulation of transcription factors and microRNAs in breast cancer.
    Wu JH; Sun YJ; Hsieh PH; Shieh GS
    Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
    Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.
    Zhang D; Wang G; Wang Y
    BMC Bioinformatics; 2014; 15 Suppl 2(Suppl 2):S10. PubMed ID: 24564526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.